Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7270 p484
11 October 2003

This article
Reprint
Photocopy


News summary

Related websites
Archives of Internal Medicine abstract (more)


Therapy can stop after H pylori eradicated

For patients with bleeding peptic ulcers that have healed following successful Helicobacter pylori eradication therapy, maintenance anti-ulcer treatment is not necessary to prevent ulcer recurrence, say Taiwanese researchers.

After H pylori eradication had been achieved (using a one-week proton pump inhibitor-based triple therapy plus three weeks of omeprazole), 82 patients were randomised to receive one of four maintenance anti-ulcer treatments (antacid suspension, colloidal bismuth subcitrate, famotidine or placebo). During the 56-month follow-up no evidence of ulcer relapse or bleeding recurrence was found in any patient.

“Successful eradication of H pylori drastically changes the natural history of bleeding peptic ulcers,” they say (Archives of Internal Medicine 2003;163:2020).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal